Tumor necrosis factor activities and cancer therapy — A perspective-Reference-Cited by-同舟云学术

Tumor necrosis factor activities and cancer therapy — A perspective

Published:1993-01 Issue:1 Volume:57 Page:79-128
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Sidhu Rajinder S.,Bollon Arthur P.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference555 articles.

1. Phase I trial of recombinant human-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer;Abbruzzese;Cancer Res.,1989

2. A possible role of glucocorticoids: an intrinsic inhibitor of the cytotoxic activity of tumor necrosis factor;Abe;Jap. J. Cancer Res.,1988

3. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase;Abuchowski;J. Biol. Chem.,1977

4. Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor α;Adachi;Cancer Immun. Immunother.,1992

5. Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes;Adamson;Arch. biochem. Biophys.,1992

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An engineered TNFR1-selective human lymphotoxin-alpha mutant delivered by an oncolytic adenovirus for tumor immunotherapy;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06

2. Induction of ferroptosis using functionalized iron-based nanoparticles for anti-cancer therapy;Materials Today Bio;2022-12

3. A novel therapeutic vaccine based on graphene oxide nanocomposite for tumor immunotherapy;Chinese Chemical Letters;2022-08

4. Nanocarrier-based activation of necroptotic cell death potentiates cancer immunotherapy;Nanoscale;2021

5. Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient;Journal of Cardiothoracic and Vascular Anesthesia;2021-01